Effects of aceclofenac and diclofenac on synovial inflammatory factors in human osteoarthritis

Clinical Drug Investigation

Volumn 14, Issue 3, 1997, Pages 226-232

  Martel Pelletier, Johanne ^a   Cloutier, Jean Marie ^b   Pelletier, Jean Pierre ^a,c  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b Pavilion St Luc ^*  (Canada)

^c NOTRE DAME HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACECLOFENAC; CYTOKINE; DICLOFENAC; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ARTICULAR CARTILAGE; CARTILAGE DEGENERATION; CARTILAGE MATRIX; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MACROPHAGE; OSTEOARTHRITIS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; SYNOVIOCYTE; SYNOVITIS; SYNOVIUM;

EID: 0030807396     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199714030-00011     Document Type: Article

References (15)

1. Pelletier JP, Martel-Pelletier J, Altman RD, et al. Collagenase and collagenolytic activity in human osteoarthritic cartilage. Arthritis Rheum 1983; 26: 63-8
2. Dodge GR, Poole AR. Immunohistochemical detection and immunochemical analysis of type II collagen degradation in human normal, rheumatoid, and osteoarthritic articular cartilages and in explants of bovine articular cartilage cultured with interleukin-1. J Clin Invest 1989; 83: 647-61
3. Hollander AP, Heathfield TF, Webber C, et al. Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay. J Clin Invest 1994; 93: 1722-32
4. Martel-Pelletier J, Pelletier JP, Malemud CJ. Activation of metalloproteases in humun osteoarthritic knee cartilage. Evidence for degradation in the core protein of sulfated proteoglycans. Ann Rheum Dis 1988; 47: 801-8
5. Zafarullah M, Martel-Pelletier J, Cloutier J-M, et al. Expression of c-fos, c-jun, jun-B, metallothionein and metalloproteinase genes in human chondrocytes. FEBS Lett 1992; 306: 169-72
6. Zafarullah M, Pelletier JP, Cloutier J-M, et al. Elevated metalloproteinase and tissue inhibitor of metalloproteinase mRNA in human osteoarthritic synovia. J Rheumatol 1993; 20: 693-7
7. Pelletier JP, Roughley P, DiBattisla JA, et al. Are cytokines involved in osteoarthritis pathophysiology? Semin Arthritis Rheum 1991; 20 Suppl. 2: 12-25
8. 2 production by human synovial cells. J Clin Invest 1986; 77: 645-8
9. Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Arthritis Rheum 1986; 29: 1039-49
10. Pelletier JP, Martel-Pelletier J. Evidence for the involvement of interleukin-1 in human OA cartilage degradation: protective effect of NSAIDs. J Rheumatol 1989; 16 Suppl. 18: 19-27
11. Fowler PD, Shadforth MF, Crook PR, et al. Plasma and synovial fluid concentrations of diclofenac sodium and its major hydroxylated metabolites during long term treatment of rheumatoid arthritis. Eur J Clin Pharmacol 1983; 25: 389-94
12. Honorato J, Caballero R, Giorgiani G, et al. Dose-analgesic response study and aceclofenac plasma levels in humans. Curr Ther Res 1990; 47:605-11
13. González, E, de la Cruz C, de Nicolás R, et al. Long term effect of nonsteroidal anti-inflammatory drugs on the production of cytokines and other inflammatory mediators by blood cells of patients with osteoarthritis. Agents Actions 1994; 41: 171-8
14. Pelletier JP, Cloutier JM, Martel-Pelletier J. In vivo effects of NSAIDs and corticosteroids on the synthesis and secretion of interleukin-1 by human osteoarthritic synovial membranes. Agents Actions 1993; 39 Suppl.: 181-93
15. Pelletier JP, McCollum R, Cloutier J-M, et al. Synthesis of metalloproteases and IL-6 in human osteoarthritic synovial membrane is an IL-1 mediated process. J Rheumatol Suppl. 1995; 43: 109-14